At meeting held on 24 January 2018
The Board of Dr Habeebullah Life Sciences at its meeting held on 24 January 2018 has approved the following -Allotment of 10 lakh convertible equity warrants on preferential basis to Promoter Company and allotment of 7 lakh equity shares pursuant to conversion of 7 lakh convertible equity warrants to the Non promoters of the company.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content